Cybin Initiates At-The-Market Equity Program of up to US$100 Million

TORONTO –(BUSINESS WIRE)–Dec. 30, 2025– Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) (“ Cybin ” or the “ Company ”), a clinical-stage breakthrough neuropsychiatry company committed to advancing mental healthcare by developing new and innovative next-generation treatment options, today